Research Partnership launches new patient Living with Ankylosing Spondylitis and non radiographic axial spondyloarthritis (nr-AxSpA) EU and US 2019 report
Living with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-AxSpA) is a quantitative study conducted online amongst 265 patients diagnosed with AS and 100 diagnosed with nr-AxSpA in the 5 EU markets (France, Germany, Italy, Spain, UK). In the US, the study is conducted with 105 AS patients and 30 nr-AxSpA patients. The report consists of quantitative 30 minute quantitative online interviews and qualitative tele-depth interviews, and will be published in the 1st quarter 2019.
Research Partnership has published a new patient Living with Diabetes (LATAM) 2018 report
Living with Diabetes is a report based on a new study conducted amongst approximately 116 Type 2 (T2D) diabetes patients in Brazil and 105 patients in Mexico. The report consists of 30-minute quantitative online and qualitative telephone interviews with T2D patients. US and EU reports are planned to launch in 2019.
Could you nudge your brand to success using behavioural economic theory?
With behavioural economics theory becoming more widely adopted, especially within the market research sector, terms such as ‘nudging’ have started to enter our vocabulary. Director Anthony Greenwood discusses what ‘nudging’ means for market research and the role it could play in marketing pharma and med-tech brands.
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST
Novel cancer therapies are offering patients new treatments and better outcomes worldwide. And recent changes in healthcare policies across APAC, such as China’s fast tracking approval of therapies for severe and rare diseases, have reignited interest in the APAC region as a strong market for oncology.
PMRC Europe round-up 2018
Earlier this month Director Paula Coyle and Associate Director An-hwa Lee attended the European Pharmaceutical Market Research Conference in Basel, Switzerland.
The event was well-received thanks to an agenda that included many thought-provoking sessions that addressed key industry issues and allowed attendees to enhance their knowledge. On day one of the conference An-hwa presented the paper ‘How to capture rare disease ‘moments-of-truth’ using online communities’ which demonstrated how, with careful set-up and management, online communities can be excellent methods for attaining an in-depth, meaningful understanding of patients with rare diseases. The session was well attended and received positive feedback from delegates.